.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp "Screen Point Medical")
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
Transpara Breast AI is the technology of choice for first large-scale RCT in the United States to evaluate the role of AI in breast cancer screening.
ScreenPoint Medical expands in Spain with SACYL - EUSOBI 2025
ScreenPoint Medical partners with SACYL to bring AI for breast cancer detection to Castilla y León, enhancing screening accuracy and efficiency in Spain.
New study assesses cost-effectiveness of Transpara as part of national screening protocol
Is it possible to reduce the total cost for the healthcare system and simultaneously boost quality-adjusted life years across a population?
Transpara AI boosts breast cancer detection without increasing reading time, study finds
Radiologists can improve breast cancer detection accuracy with Transpara, according to new research.
As imaging volume increases, breast radiology workflow must adapt
Radiology faces an inflection point. Can systemic solutions, including AI, prioritize both patient outcomes and radiologist well-being?
Breast imaging is awash in data – Artificial Intelligence can help
Breast imaging has unique stressors compared to other areas of radiology that can contribute to radiologist fatigue and error: what can be done?